Complete response of hepatocellular carcinoma with sorafenib and 90Y radioembolization

Current Oncology

Volumn 17, Issue 5, 2010, Pages 67-69

  Chaudhury, P K ^a   Hassanain, M ^a   Bouteaud, J M ^a   Alcindor, T ^b   Nudo, C G ^a   Valenti, D ^a   Cabrera, T ^a   Kavan, P ^b   Feteih, I ^a   Metrakos, P ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Cancer; Gastrointestinal; Oncology; Surgery

Indexed keywords

ALPHA FETOPROTEIN; GEMCITABINE; OXALIPLATIN; SORAFENIB; THERASPHERE; UNCLASSIFIED DRUG; YTTRIUM 90;

ADRENAL METASTASIS; ADRENALECTOMY; ADULT; ARTICLE; CASE REPORT; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG RESPONSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER RESECTION; LYMPH NODE METASTASIS; MALE; NAUSEA; PATIENT ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR VOLUME; VOMITING;

EID: 78149448421     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v17i5.609     Document Type: Article

References (7)

1. Parkin D, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Llovet J, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-17.
3. Llovet J, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-90.
4. Llovet J, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008;48 (suppl 1):S20-37.
5. Ibrahim SM, Lewandowski RJ, Sato KT, et al. Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review. World J Gastroenterol 2008; 14:1664-9.
6. Ibrahim SM, Nikolaidis P, Miller FH, et al. Radiologic findings following Y90 radioembolization for primary liver malignancies. Abdom Imaging 2009;34:566-81.
7. Senan S, Smit EF. Design of clinical trials of radiation combined with antiangiogenic therapy. Oncologist 2007;12:465-77.